Scleroderma-like reaction induced by uracil-tegafur (UFT), a second-generation anticancer agent - 05/09/11
Abstract |
UFT, a combination of uracil and tegafur, is a second-generation anticancer agent. UFT has been used in Japan, other Asian countries, South America, and Russia. Recently, UFT has been extensively studied for colorectal, pancreatic, and various types of cancer in North America and Europe, especially with leukovorin. We report a case of a scleroderma-like reaction induced by long-term administration of UFT. This is the first report of UFT-induced scleroderma-like reaction. (J Am Acad Dermatol 2000;42:519-20.)
Le texte complet de cet article est disponible en PDF.Plan
Reprint requests: Takeshi Kono, MD, Department of Dermatology, Osaka City University Medical School, 1-4-7, Asahimachi, Abeno-ku, Osaka 545-8585, Japan. |
Vol 42 - N° 3
P. 519-520 - mars 2000 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?